Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.7 |
mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.7 |